ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

NCI Changes Deadlines For Two RFAS

July 18, 1997

In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives

August 29, 1975

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

House subcommittee proposes 2.8 percent increase for NIH, NCI.

July 16, 2004

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009